It is very likely that you currently find yourself in a place of uncertainty and distress regarding the COVID-19 outbreak. Information and recommendations are changing daily in order to keep our communities as safe as possible.

Here is some guidance from the Global Initiative for Chronic Obstructive Lung Disease (GOLD):

  • GOLD recognizes people with COPD are amongst the worst affected by COVID-19 and GOLD is working with WHO to try to minimize the impact of the infection.
  • GOLD strongly encourages people with COPD to follow the advice of the public health teams in their own countries to try to minimize the chance of becoming infected and on when and how to seek help if they show symptoms of the infection.
  • GOLD is not aware of any scientific evidence to support that inhaled (or oral) corticosteroids should be avoided in patients with COPD during the COVID-19 epidemic.
  • COPD patients should maintain their regular therapy.
  • Oxygen therapy should be provided if needed following standard recommendations.
  • As new information becomes available, please continue to follow recommendations on management from the authorities in your own country.
Click here for GOLD

Where to get more information:

  • Health Canada

    Follow the advice of Health Canada for being prepared for COVID-19 and how you, as an individual, can protect yourself and prevent the spread in your community.

  • Canadian Thoracic Society

    Read what the Canadian Thoracic Society (CTS) suggests for Healthcare Professionals during the COVID-19 outbreak – compiled information from multiple health organizations.

  • Centre for Disease Control and Prevention

    Read what the Center for Disease Control and Prevention (CDC) in the USA suggests for protecting yourself and learn what you need to know about COVID-19.

  • World Health Organization

    For further information, go to the World Health Organization (WHO) web page.

  • COPD Foundation

    Learn more information about coronavirus and the COPD community and listen to a recorded webinar hosted by the COPD Foundation in the USA.